Printer Friendly

The results of a study published in the American Journal of Medicine suggest there is an association between aspirin use and a decreased risk of developing type 2 diabetes.

"Analytic studies on aspirin or non-aspirin nonsteroidal antiinflammatory drugs (NSAIDs) and the risk of diabetes" outside of clinical trials are limited, write Dr. Yasuaki Hayashino, of the University Graduate School of Medicine, Kyoto, Japan, and colleagues. To investigate, the researchers analyzed data from the Physician's Health Study, which includes 22,071 apparently healthy male physicians, and has accumulated 22 years of follow-up data. The participants provide self reports of history of diabetes, aspirin use, and various lifestyle factors at study entry and in yearly follow-up questionnaires. A total of 1719 cases of diabetes were reported during follow-up. The men who reported taking any aspirin were 14% less likely to develop diabetes, compared with those who did not take aspirin.

Non-aspirin NSAIDs were not associated with a decreased risk of developing diabetes. "Decreased risk of type 2 diabetes may be added to the list of clinical benefits of aspirin," Hayashino and colleagues conclude. "Future studies are warranted to further investigate this association."
COPYRIGHT 2009 MedContent Media, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Article Type:Brief article
Geographic Code:1USA
Date:Apr 27, 2009
Previous Article:A Schering-Plough Corp (Kenilworth NJ) drug knocked the hepatitis C virus down to undetectable levels in three-fourths of patients in a mid-stage...
Next Article:Vertex Pharmaceutical Inc's (Cambridge MA) experimental hepatitis C drug telaprevir wiped out signs of the infection in half of patients with...

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters